Source comparison
The Mechanistic Truth About Tesamorelin vs Exogenous GH
Here's the honest answer: tesamorelin and exogenous recombinant GH are not interchangeable despite both elevating growth hormone. The delivery mechanism determines the physiological outcome. Exogenous GH floods peripheral tissues with continuous, non-pulsatile
This comparison does not assign a generated winner or score.
- Here's the honest answer: tesamorelin and exogenous recombinant GH are not interchangeable despite both elevating growth hormone. The delivery mechanism determines the physiological outcome. Exogenous GH floods peripheral tissues with continuous, non-pulsatile GH exposure, which suppresses endogenous GHRH secretion, shuts down pituitary somatotroph activity, and creates insulin resistance through chronic activation of GH receptor signaling in liver and muscle. The metabolic cost is significant: studies of GH administration in non-deficient adults consistently show fasting glucose increases of 5–15mg/dL and insulin resistance (HOMA-IR elevation) within 12 weeks.
- Tesamorelin sidesteps this entirely. By amplifying the body's own GH pulses rather than replacing them, it maintains the inter-pulse troughs that allow insulin sensitivity to recover between secretory bursts. The NMES trial explicitly measured glucose metabolism endpoints and found no statistically significant change in fasting glucose (+1.2mg/dL, p=0.19) or HbA1c (−0.01%, p=0.68) after 26 weeks of daily tesamorelin despite robust VAT reduction and IGF-1 elevation. That outcome is mechanistically impossible with exogenous GH at equipotent doses. The reason tesamorelin remains the only FDA-approved GH-modulating therapy for lipodystrophy is not marketing. It's because the mechanism studies prove it delivers the benefits of GH (lipolysis, IGF-1 elevation, lean mass preservation) without the liabilities (hyperglycemia, receptor desensitization, feedback suppression). For research contexts where sustained metabolic effects matter more than short-term peak GH levels, this distinction is eve